Annual EBITDA
-$32.97 M
-$9.41 M-39.96%
December 31, 2023
Summary
- As of February 8, 2025, ELTX annual EBITDA is -$32.97 million, with the most recent change of -$9.41 million (-39.96%) on December 31, 2023.
- During the last 3 years, ELTX annual EBITDA has fallen by -$17.44 million (-112.30%).
- ELTX annual EBITDA is now -169.46% below its all-time high of -$12.23 million, reached on December 31, 2019.
Performance
ELTX EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$18.41 M
-$11.52 M-167.33%
September 30, 2024
Summary
- As of February 8, 2025, ELTX quarterly EBITDA is -$18.41 million, with the most recent change of -$11.52 million (-167.33%) on September 30, 2024.
- Over the past year, ELTX quarterly EBITDA has dropped by -$8.03 million (-77.30%).
- ELTX quarterly EBITDA is now -520.59% below its all-time high of -$2.97 million, reached on March 31, 2020.
Performance
ELTX Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$45.46 M
-$8.03 M-21.44%
September 30, 2024
Summary
- As of February 8, 2025, ELTX TTM EBITDA is -$45.46 million, with the most recent change of -$8.03 million (-21.44%) on September 30, 2024.
- Over the past year, ELTX TTM EBITDA has dropped by -$14.89 million (-48.71%).
- ELTX TTM EBITDA is now -1432.34% below its all-time high of -$2.97 million, reached on March 31, 2020.
Performance
ELTX TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
ELTX EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -40.0% | -77.3% | -48.7% |
| 3 y3 years | -112.3% | -143.0% | -75.5% |
| 5 y5 years | -169.5% | -143.0% | -75.5% |
ELTX EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -40.0% | at low | -216.0% | at low | -640.3% | at low |
| 5 y | 5-year | -169.5% | at low | -520.6% | at low | -1432.3% | at low |
| alltime | all time | -169.5% | at low | -520.6% | at low | -1432.3% | at low |
Elicio Therapeutics EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$18.41 M(+167.3%) | -$45.46 M(+21.4%) |
| Jun 2024 | - | -$6.89 M(-40.1%) | -$37.43 M(+1.5%) |
| Mar 2024 | - | -$11.50 M(+32.8%) | -$36.89 M(+11.9%) |
| Dec 2023 | -$32.97 M(+40.0%) | -$8.66 M(-16.6%) | -$32.97 M(+7.8%) |
| Sep 2023 | - | -$10.38 M(+63.7%) | -$30.57 M(+17.5%) |
| Jun 2023 | - | -$6.34 M(-16.3%) | -$26.01 M(+0.4%) |
| Mar 2023 | - | -$7.58 M(+20.9%) | -$25.90 M(+41.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2022 | -$23.55 M(-6.8%) | -$6.26 M(+7.5%) | -$18.32 M(+52.0%) |
| Sep 2022 | - | -$5.83 M(-6.5%) | -$12.06 M(+93.5%) |
| Jun 2022 | - | -$6.23 M(+1.5%) | -$6.23 M(+1.5%) |
| Dec 2021 | -$25.27 M(+62.8%) | - | - |
| Mar 2021 | - | -$6.14 M(+107.0%) | -$6.14 M(+107.0%) |
| Dec 2020 | -$15.53 M(+26.9%) | - | - |
| Mar 2020 | - | -$2.97 M | -$2.97 M |
| Dec 2019 | -$12.23 M | - | - |
FAQ
- What is Elicio Therapeutics annual EBITDA?
- What is the all time high annual EBITDA for Elicio Therapeutics?
- What is Elicio Therapeutics annual EBITDA year-on-year change?
- What is Elicio Therapeutics quarterly EBITDA?
- What is the all time high quarterly EBITDA for Elicio Therapeutics?
- What is Elicio Therapeutics quarterly EBITDA year-on-year change?
- What is Elicio Therapeutics TTM EBITDA?
- What is the all time high TTM EBITDA for Elicio Therapeutics?
- What is Elicio Therapeutics TTM EBITDA year-on-year change?
What is Elicio Therapeutics annual EBITDA?
The current annual EBITDA of ELTX is -$32.97 M
What is the all time high annual EBITDA for Elicio Therapeutics?
Elicio Therapeutics all-time high annual EBITDA is -$12.23 M
What is Elicio Therapeutics annual EBITDA year-on-year change?
Over the past year, ELTX annual EBITDA has changed by -$9.41 M (-39.96%)
What is Elicio Therapeutics quarterly EBITDA?
The current quarterly EBITDA of ELTX is -$18.41 M
What is the all time high quarterly EBITDA for Elicio Therapeutics?
Elicio Therapeutics all-time high quarterly EBITDA is -$2.97 M
What is Elicio Therapeutics quarterly EBITDA year-on-year change?
Over the past year, ELTX quarterly EBITDA has changed by -$8.03 M (-77.30%)
What is Elicio Therapeutics TTM EBITDA?
The current TTM EBITDA of ELTX is -$45.46 M
What is the all time high TTM EBITDA for Elicio Therapeutics?
Elicio Therapeutics all-time high TTM EBITDA is -$2.97 M
What is Elicio Therapeutics TTM EBITDA year-on-year change?
Over the past year, ELTX TTM EBITDA has changed by -$14.89 M (-48.71%)